CarcinogenesisGenetic & Genomic MedicinePeer-reviewed journal article
Mutational signatures and increased retrotransposon insertions in Xeroderma Pigmentosum variant skin tumors
Camila CorradiiD, Juliana Brandstetter VilariD, Vanessa Candiotti BuzattoiD, Tiago Antônio de SouzaiD, Ligia Pereira CastroiD, Veridiana MunfordiD, Rodrigo De VecchiiD, Pedro A. F. GalanteiD, Fernanda Orpinelli Ramos do Rego, Thiago L. A. MilleriD, José Leonel BuzzoiD, Mírian Nacagami SottoiD, Paulo Hilário Nascimento SaldivaiD, Jocelânio W. de OliveiraiD, Sulamita Costa Wirth ChaibubiD, Alain R. SarasiniD, Carlos Frederico Martins MenckiD
Abstract
Xeroderma Pigmentosum variant (XP-V) is an autosomal recessive disease with an increased risk to develop cutaneous neoplasms in sunlight exposed regions. These cells are deficient in the translesion synthesis DNA polymerase eta. Eleven skin tumors from a genetic cluster of XP-V patients had their exome sequenced. Mutational signatures identified for most tumors were related to ultraviolet exposure, such as C>T transitions targeted to pyrimidine dimers. However, four samples carry different mutational signatures, with C>A mutations associated with tobacco usage. Basal cell carcinomas showed a distinct C>A mutation spectra reflecting a novel mutational signature. Higher levels for retroposon insertions were detected in the XP-V tumors, compared to non-XP skin tumors. The results reveal other possible causes for XP-V tumors and the involvement of polymerase eta in suppressing retrotransposition. The expected high mutation burden, found in most of these tumors, renders these XP patients good candidates for immunotherapy with checkpoint blockers.
- organism: human
- assay: whole-exome sequencing
- research focus: differential expression
- research focus: variant calling
- research focus: benchmarking
- approach: statistical model
- Citations
- 12
- FWCI
- 1.39
- Field percentile
- top 20%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Analysis of Skin Cancers from Xeroderma Pigmentosum Patients Reveals Heterogeneous UV-Induced Mutational Profiles Shaped by DNA Repair
A. A. Yurchenko, F. Rajabi, … S. I. Nikolaev·bioRxiv·Oct 14, 2022
- XPC deficiency increases risk of hematologic malignancies through mutator phenotype and characteristic mutational signature
A. A. Yurchenko, I. Padioleau, … S. Nikolaev·bioRxiv·Jul 13, 2020
- Senotherapeutic potential against xeroderma pigmentosum
王雪冰, Masako Nishida, … Takeshi Fukumoto·Stem Cell Research & TherapyPeer-reviewed·Oct 5, 2026
- Uniquely high spontaneous mutational load in blood cells of XP-C patients
Gordon Fan-Huang, Elizabeth L. Schmidt, … Alexander Y. Maslov·bioRxiv·Jul 16, 2025
- Type I Interferon Signaling Defines a Novel Disease Signature in Xeroderma Pigmentosum C Human Keratinocytes
Ali Nasrallah, Hamid Reza Rezvani, … Walid Rachidi·Scientific ReportsPeer-reviewed·Jan 29, 2026
- Whole exome-sequencing of vitiligo lesions indicate lower burden of somatic variations: implications in risk for non-melanoma skin cancers
Iti Gupta, Shambhavi Shankrit, … Vivek T. Natarajan·Journal of Investigative DermatologyPeer-reviewed·Dec 16, 2022